Nanomedicine News

RSS

Researchers Combine Gold Nanoparticles with Small Interfering RNAs to Counter Glioblastoma

Glioblastoma multiforme (GBM), the brain cancer that killed Sen. Edward Kennedy and kills approximately 13,000 Americans a year, is aggressive and incurable. Now a Northwestern University research team is the first to demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in animals with the deadly disease.

31 Oct 2013

Researchers Develop Microbeam Emitter Using Carbon Nanotube-Based X-Ray Source Array Technology

Microbeam radiation therapy (MRT) provides tremendous promise for cancer patients through its ability to destroy tumor cells while protecting surrounding healthy tissue. Yet research into its clinical use has been limited by the sheer size of the technology required to generate the beams. Until now, administering MRT required massive electron accelerators known as synchrotrons.

31 Oct 2013

New Iron Oxide Nanoparticle Delivers and Monitors Drug Release in Real Time

UNSW chemical engineers have synthesised a new iron oxide nanoparticle that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.

30 Oct 2013

Unique Dual-Surface Nanostructured Carrier Improves Drug Delivery to Cancer Cells

University of Cincinnati researchers have developed a unique nanostructure that can, because of its dual-surface structure, serve as an improved “all-in-one tool” against cancer.

29 Oct 2013

NSF Awards CWRU $424,000 Grant to Streamline Manufacturing for Two-Sided Nanoparticles

A pair of Case Western Reserve University researchers have received a $424,000 grant from the National Science Foundation's Division of Civil, Mechanical and Manufacturing Innovation, to streamline manufacturing and assembly for two-sided nanoparticles.

29 Oct 2013

Tekmira Presents Preclinical Data Demonstrating LNP Technology Innovations at mRNA Health Conference

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced that data demonstrating its ongoing lipid nanoparticle (LNP) technology innovations, including the enablement of messenger RNA (mRNA), were presented at the 1st International mRNA Health Conference taking place in Tubingen, Germany from October 23-24, 2013 by Tekmira's Chief Scientific Officer, Dr. Ian MacLachlan.

25 Oct 2013

EuroNanoMed II to Fund €7 Million to Eight European Nanomedicine Research Projects

EuroNanoMed II, a European funding initiative under the ERA-NET scheme of the European Commission’s 7th Framework Programme, announced on the projects that will be funded following its 2013 joint transnational call for collaborative research projects.

25 Oct 2013

Nanomedicine News

Researchers Combine Gold Nanoparticles with Small Interfering RNAs to Counter Glioblastoma

Researchers Develop Microbeam Emitter Using Carbon Nanotube-Based X-Ray Source Array Technology

New Iron Oxide Nanoparticle Delivers and Monitors Drug Release in Real Time

Unique Dual-Surface Nanostructured Carrier Improves Drug Delivery to Cancer Cells

NSF Awards CWRU $424,000 Grant to Streamline Manufacturing for Two-Sided Nanoparticles

Tekmira Presents Preclinical Data Demonstrating LNP Technology Innovations at mRNA Health Conference

EuroNanoMed II to Fund €7 Million to Eight European Nanomedicine Research Projects

Johns Hopkins University and imec to Advance Silicon Nanotech Applications in Healthcare

Researchers Work on Development of Nanofiber-Reinforced Hydrogel Biomaterial for Knee Injuries

Nanotherapeutics Breaks Ground on Advanced Development and Manufacturing Center in Alachua, Florida

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Enhancing Material Properties through Nanotube Encapsulation

Modeling the Growth of Hexagonal Boron Nitride for Next-Generation Applications

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials